A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Odom, D., Brogan, A., Talbird, S., & Schenkel, B. (2013). A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis. Value in Health, 16(3), A112-A112.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

View All Experts
Dawn Odom
Navigate to Dawn Odom

Dawn Odom